Chen X 2020.
Study characteristics | |||
Patient Sampling |
Purpose: diagnosis COVID‐19 pneumonia ‐ to identify differences in CT imaging and clinical manifestations between pneumonia patients with and without COVID‐19, and to develop and validate a diagnostic model for COVID‐19 based on radiological semantic and clinical features Design: cross‐sectional multicentre retrospective study Recruitment: cases: consecutive patients with COVID‐19 admitted in 5 independent hospitals controls: at the same period, another 66 consecutive pneumonia patients without COVID‐19 from Meizhou People’s Hospital Sample size: n = 136 (cases = 70) Inclusion criteria: patients admitted with COVID‐19 pneumonia (cases) and patients admitted with non‐COVID‐19 pneumonia (controls) Exclusion criteria: not specified for cases except those from 1 hospital (Meizhou), for cases and controls in Meizhou: after chest CT neoplasm, tuberculosis, pulmonary oedema, pulmonary contusion, aspiration pneumonia, bronchitis, any local or systemic treatment before CT scan, normal CT image without epidemiological history |
||
Patient characteristics and setting |
Facility cases: pneumonia patients with positive SARS‐CoV‐2 test Facility controls: CT pneumonia patients with consecutive negative RT‐PCR Country: China Dates: 1 January 2020‐8 February 2020 Symptoms and severity: pneumonia patients for cases and control; unclear severity of cases Demographics: M/F: cases 41/29, controls 43/23 mean age: cases 42.9 range, 16‐69 years, controls 46.7 range, 0.3‐93 years Exposure history: data about exposure to epidemic centres collected, but no results in the study nor in appendices |
||
Index tests |
|
||
Target condition and reference standard(s) |
|
||
Flow and timing | Time interval not specified | ||
Comparative | |||
Notes | |||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | Yes | ||
Was a case‐control design avoided? | Yes | ||
Did the study avoid inappropriate exclusions? | Yes | ||
Did the study avoid inappropriate inclusions? | No | ||
Could the selection of patients have introduced bias? | High risk | ||
Are there concerns that the included patients and setting do not match the review question? | High | ||
DOMAIN 2: Index Test (All tests) | |||
Were the index test results interpreted without knowledge of the results of the reference standard? | Unclear | ||
If a threshold was used, was it pre‐specified? | No | ||
Could the conduct or interpretation of the index test have introduced bias? | Unclear risk | ||
Are there concerns that the index test, its conduct, or interpretation differ from the review question? | Unclear | ||
DOMAIN 3: Reference Standard | |||
Is the reference standards likely to correctly classify the target condition? | Yes | ||
Were the reference standard results interpreted without knowledge of the results of the index tests? | Yes | ||
Could the reference standard, its conduct, or its interpretation have introduced bias? | Low risk | ||
Are there concerns that the target condition as defined by the reference standard does not match the question? | Low concern | ||
DOMAIN 4: Flow and Timing | |||
Was there an appropriate interval between index test and reference standard? | Unclear | ||
Did all patients receive the same reference standard? | Yes | ||
Were all patients included in the analysis? | Yes | ||
Could the patient flow have introduced bias? | Low risk |